IQV · IQVIA Holdings Inc.
$191.142026-07-21Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Life Sciences Tools & Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$170
-10.8% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($158 · $322) Analysts Range ($185 · $250) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $15.0B | — | 13.2% | 5.5% | $1.9B | −$721MM | $1.1B | 9.6% | — | 10.2% | $18.3B | $8.00 | — |
| 2024.Q4 | $15.0B | 0.0% | 13.2% | 18.0% | $1.6B | −$40MM | $1.6B | 10.3% | — | 8.9% | $18.2B | $8.00 | — |
| 2025.Q1 | $15.4B | 2.8% | 14.3% | 19.0% | $1.8B | −$71MM | $1.7B | 9.9% | — | 9.7% | $18.4B | $8.09 | — |
| 2025.Q4 | $15.4B | 0.0% | 14.3% | 15.6% | $1.9B | −$427MM | $1.4B | 10.5% | — | 9.6% | $20.3B | $8.09 | — |
| 2026.Q1 | $16.6B | 8.0% | 13.9% | 15.3% | $2.0B | −$327MM | $1.6B | 9.7% | — | 9.7% | $20.1B | $8.16 | 14.1 |
| italics below = DCF projection · 10yr Rev CAGR: 5% |
| 2027.Q1 | $17.5B | +5.4% | 14.1% | 15.8% | $2.1B | −$352MM | $1.7B | 9.6% | $1.6B | 10.3% | $20.5B | $12.29 | 15.6 |
| 2028.Q1 | $18.5B | +5.5% | 14.9% | 16.3% | $2.3B | −$408MM | $1.9B | 9.5% | $1.6B | 11.2% | $20.9B | $13.62 | 14.0 |
| 2029.Q1 | $19.5B | +5.6% | 16.0% | 16.7% | $2.6B | −$473MM | $2.1B | 9.4% | $1.6B | 12.3% | $21.3B | $15.30 | 12.5 |
| 2030.Q1 | $20.7B | +5.8% | 16.9% | 17.2% | $2.9B | −$567MM | $2.3B | 9.3% | $1.6B | 13.4% | $21.9B | $17.01 | 11.2 |
| 2031.Q1 | $21.7B | +5.2% | 16.9% | 17.7% | $3.0B | −$593MM | $2.4B | 9.2% | $1.5B | 13.6% | $22.5B | $17.79 | 10.7 |
|
| Term. Yr+ | $28.3B | 4.1% | 19.6% | 20.0% | $4.4B | −$1.4B | $3.0B | 8.6% | $28.0B | 13.1% | — | — | — |
Active scenario IV: $170 (-10.8% vs market)